Option chain shows key data for Bega Cheese's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Bega Cheese.

Bega Cheese (OTC:BGCHY) Stock, Option Chain

Bega Group is an Australia-based dairy processor and food manufacturer of well-known brands including Bega Cheese and Vegemite. Bega operates two segments: The branded segment produces consumer packaged goods primarily sold through the supermarket and foodservice channels, while the bulk segment produces commodity dairy ingredients primarily sold through the business-to-business channel.

BEGA CHEESE LTD UNSP/ADR by Bega Cheese Ltd

Bega Cheese Ltd

InflaRx&nbsp;N.V.&nbsp;(Nasdaq:&nbsp;IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the European Commission (EC) has granted marketing authorization under exceptional circumstances for GOHIBIC&#xAE; (vilobelimab) for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) who are receiving systemic corticosteroids as part of standard of care and receiving invasive mechanical ventilation (IMV) with or without extracorporeal membrane oxygenation (ECMO). GOHIBIC is the first and only treatment approved in the European Union for the treatment of SARS-CoV-2-induced ARDS.

Biotech

News

Global

General

IFRX

InflaRx Receives European Commission Approval For GOHIBIC For The Treatment Of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Wednesday.
The Dow traded up 1.68% to 43,232.26 while the NASDAQ rose 2.34% to 19,489.33. The S&amp;P 500 also rose, gaining, 1.77% to 5,946.09.
Check This Out: <a href="https://www.benzinga.com/25/01/42998360/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Consumer discretionary shares surged by 2.6% on Tuesday.
In trading on Tuesday, consumer staples shares rose by just 0.2%.
Top Headline
Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) reported better-than-expected fourth-quarter financial results.
Goldman Sachs reported fourth-quarter revenue of $13.87 billion, beating the consensus of $12.39 billion. Revenue increased by 23% year-over-year, reflecting growth across all segments, with significant growth in Global Banking &amp; Markets.
Goldman Sachs clocked fourth-quarter GAAP EPS of $11.95, beating the consensus of $8.30. Full-year GAAP EPS was $40.54, beating the consensus of $36.55.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Safe &amp; Green Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares shot up 154% to $1.37. Safe &amp; Green Holdings announced the execution of a binding Letter of Intent to acquire 100% of the outstanding securities of New Asia Holdings Inc.</li>
<li>Shares of Vision Marine Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>)got a boost, surging 41% to $1.97 after the company announced it filed its latest patent application with the United States Patent and Trademark Office for a Battery Authentication Encryption Technology.</li>
<li>Compass Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COMP#NYSE">COMP</a>) shares were also up, gaining 16% to $6.49 after the company raised its FY24 guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Keros Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) shares dropped 15% to $10.64 after the company announced an update on its Phase 2 TROPOS trial and halted all dosing based on the ongoing safety review.</li>
<li>Shares of Aclarion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) were down 55% to $0.043 after the company reported the pricing of $14.4m public offering of common stock and warrants.</li>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) was down, falling 39% to $0.25 after the company announced the pricing of a $1.5 million public offering.</li>
</ul>
Commodities In commodity news, oil traded up 2% to $79.00 while gold traded up 0.6% at $2,699.30.
Silver traded up 2.2% to $31.005 on Wednesday, while copper rose 0.8% to $4.3775.
Euro zone
European shares were higher today. The eurozone's STOXX 600 surged 1.27%, Germany's DAX 40 gained 1.53% and France's CAC 40 gained 0.95%. Spain's IBEX 35 Index gained 1.20%, while London's FTSE 100 gained 1.04%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 0.08%, China's Shanghai Composite Index declining 0.43%, Hong Kong's Hang Seng Index gaining 0.34% and India's BSE Sensex rising 0.29%.
Economics
The headline Consumer Price Index rose 2.9% year-over-year in December, according to Wednesday's data from the Bureau of Labor Statistics.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42997542/top-3-tech-and-telecom-stocks-that-may-explode-this-quarter">Top 3 Tech And Telecom Stocks That May Explode This Quarter</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ACON

AZTR

COMP

KROS

SGBX

VMAR

Nasdaq Surges Over 2%; Goldman Sachs Posts Upbeat Q4 Results

Stifel analyst Bert Subin maintains Schneider National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNDR#NYSE">SNDR</a>) with a Hold and raises the price target from $27 to $28.

Price Target

Analyst Ratings

SNDR

Stifel Maintains Hold on Schneider National, Raises Price Target to $28

<a href="https://www.chicagofed.org/publications/speeches/2025/jan-15-midwest-economic-forecast" title="https://www.chicagofed.org/publications/speeches/2025/jan-15-midwest-economic-forecast">https://www.chicagofed.org/publications/speeches/2025/jan-15-midwest-economic-forecast</a>

Macro Economic Events

Economics

Federal Reserve

Fed's Goolsbee Says Pretty Confident We'll Get Inflation To 2%, That's A Promise The Fed Has Made

Whales with a lot of money to spend have taken a noticeably bullish stance on Rivian Automotive.
Looking at options history for Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) we detected 25 trades.
If we consider the specifics of each trade, it is accurate to state that 68% of the investors opened trades with bullish expectations and 32% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $136,881 and 22, calls, for a total amount of $1,893,248.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $10.0 and $30.0 for Rivian Automotive, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Rivian Automotive's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Rivian Automotive's whale activity within a strike price range from $10.0 to $30.0 in the last 30 days. 
<h3>Rivian Automotive Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736962231_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$6.45</td>
<td>$6.1</td>
<td>$6.1</td>
<td>$10.00</td>
<td>$541.0K</td>
<td>15.4K</td>
<td>1.1K</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$6.05</td>
<td>$5.95</td>
<td>$5.95</td>
<td>$10.00</td>
<td>$177.9K</td>
<td>15.4K</td>
<td>1.1K</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$6.1</td>
<td>$5.9</td>
<td>$6.1</td>
<td>$10.00</td>
<td>$165.9K</td>
<td>15.4K</td>
<td>0</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.7</td>
<td>$4.6</td>
<td>$4.6</td>
<td>$12.50</td>
<td>$131.5K</td>
<td>6.9K</td>
<td>2</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$5.8</td>
<td>$5.7</td>
<td>$5.7</td>
<td>$10.00</td>
<td>$108.3K</td>
<td>2.3K</td>
<td>191</td>
</tr>
</tbody>
</table>

<h3>About Rivian Automotive</h3>
Rivian Automotive Inc designs, develops, and manufactures category-defining electric vehicles and accessories. In the consumer market, the company launched the R1 platform with the first generation of consumer vehicles: the R1T, a two-row, five-passenger pickup truck, and the R1S, a three-row, seven-passenger sport utility vehicle (SUV).
<h3>Current Position of Rivian Automotive</h3>
<ul>
<li>Trading volume stands at 16,330,197, with RIVN's price up by 4.87%, positioned at $13.99.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 36 days.</li>
</ul>
<h3>What Analysts Are Saying About Rivian Automotive</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $13.666666666666666.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Truist Securities has revised its rating downward to Hold, adjusting the price target to $12. 
&#x2A; An analyst from Baird downgraded its action to Neutral with a price target of $16. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $13. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Rivian Automotive, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

RIVN

This Is What Whales Are Betting On Rivian Automotive

On Tuesday, the Federal Trade Commission released a second interim staff report detailing significant price markups on specialty generic drugs by UnitedHealth Group Inc.'s (NYSE: UNH) Optum unit, CVS Health Corp.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) CVS Caremark, and Cigna Corp.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) Express Scripts.
The <a href="https://www.ftc.gov/news-events/news/press-releases/2025/01/ftc-releases-second-interim-staff-report-prescription-drug-middlemen" target="_blank" rel="noreferrer noopener">report</a> found that these companies generated substantial revenue from markups on essential medications used to treat cancer, HIV, and other critical conditions, often inflating costs by hundreds to thousands of percentage points. 
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/24/11/42097386/cvs-healthcignaunitedhealths-pharmacy-benefit-managers-accuse-ftc-of-overreach-in-effort-to-reshape-drug-rebate-system" rel="noreferrer noopener">Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System</a>
From 2017 to 2022, the three largest pharmacy benefit managers and their affiliated pharmacies accrued over $7.3 billion in dispensing revenue that exceeded the drugs' estimated acquisition costs.
The report builds on a prior FTC analysis from July 2024, which revealed that PBM-affiliated pharmacies garnered 68% of specialty drug dispensing revenue in 2023, up <a target="_blank" href="https://www.benzinga.com/government/24/07/39695378/ftc-investigation-uncovers-anti-competitive-practices-by-handful-of-pharmacy-benefit-managers-includ" rel="noreferrer noopener">from 54% in 2016</a>.
This occurred as costs to patients, employers, and health plan sponsors steadily rose. FTC Chair Lina Khan emphasized the need for the agency to continue investigating practices that may inflate drug costs and harm independent pharmacies.
The report also identified alarming trends in how PBMs handle specialty generic drugs.
PBM-affiliated pharmacies dispensed a disproportionate share of the most profitable prescriptions, suggesting these companies may be steering business toward their operations. This practice resulted in billions of dollars in additional income, including $1.4 billion from spread pricing — a strategy where PBMs bill plan sponsors more than they reimburse pharmacies for drugs.
The FTC's findings underscore the growing financial impact of PBMs on health care costs.
Between 2017 and 2021, plan sponsors' spending on specialty generic drugs increased at a compound annual growth rate of 21% for commercial claims, with patients' cost-sharing also climbing significantly.
In 2021 alone, plan sponsors paid $4.8 billion, while patients spent $297 million.
The study analyzed 51 specialty generic drugs, including critical medications such as Ampyra, Gleevec, Sensipar, and Myfortic.
These drugs accounted for a significant portion of operating income for the PBMs' parent healthcare conglomerates, with the top 10 drugs alone generating $6.2 billion in dispensing revenue above acquisition costs.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42997019/asia-markets-mixed-europe-advances-gold-surges-1-dollar-dips-global-markets-today-while-us-slept" target="_blank" rel="noreferrer noopener">Dollar Cools Off Ahead Of Bank Earnings, Asia Markets Mixed, Europe Up &#8211; Global Markets Today While US Slept</a></li>
</ul>
Photo by Martin Gregor via Shutterstock

Large Cap

Regulations

Health Care

FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs

Deep-pocketed investors have adopted a bearish approach towards NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NEE usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for NextEra Energy. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 50% bearish. Among these notable options, 7 are puts, totaling $1,021,527, and 5 are calls, amounting to $280,539.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $65.0 to $85.0 for NextEra Energy over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in NextEra Energy's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to NextEra Energy's substantial trades, within a strike price spectrum from $65.0 to $85.0 over the preceding 30 days.
<h3>NextEra Energy Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736962226_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.1</td>
<td>$4.9</td>
<td>$4.91</td>
<td>$65.00</td>
<td>$557.7K</td>
<td>1.3K</td>
<td>1.1K</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/31/25</td>
<td>$1.86</td>
<td>$1.85</td>
<td>$1.85</td>
<td>$70.00</td>
<td>$129.5K</td>
<td>266</td>
<td>22</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.45</td>
<td>$2.34</td>
<td>$2.35</td>
<td>$70.00</td>
<td>$118.9K</td>
<td>545</td>
<td>1.4K</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$2.4</td>
<td>$2.39</td>
<td>$2.4</td>
<td>$70.00</td>
<td>$118.6K</td>
<td>545</td>
<td>989</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.53</td>
<td>$2.42</td>
<td>$2.43</td>
<td>$70.00</td>
<td>$104.7K</td>
<td>545</td>
<td>64</td>
</tr>
</tbody>
</table>

<h3>About NextEra Energy</h3>
NextEra Energy's regulated utility, Florida Power &amp; Light, is the largest rate-regulated utility in Florida. The utility distributes power to nearly 6 million customer accounts in Florida and owns 34 gigawatts of generation. FP&amp;L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with more than 34 GW of generation capacity, including natural gas, nuclear, wind, and solar.
<h3>Present Market Standing of NextEra Energy</h3>
<ul>
<li>With a trading volume of 4,150,671, the price of NEE is up by 2.24%, reaching $69.5.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 9 days from now.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for NextEra Energy with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

What the Options Market Tells Us About NextEra Energy

Investors with a lot of money to spend have taken a bearish stance on Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BX, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 11 options trades for Blackstone.
This isn't normal.
The overall sentiment of these big-money traders is split between 18% bullish and 54%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $40,983, and 10, calls, for a total amount of $607,837.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $115.0 to $195.0 for Blackstone over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Blackstone's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Blackstone's significant trades, within a strike price range of $115.0 to $195.0, over the past month.
<h3>Blackstone Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736962220_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.7</td>
<td>$5.6</td>
<td>$6.45</td>
<td>$170.00</td>
<td>$129.0K</td>
<td>3.7K</td>
<td align="right">200</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$41.0</td>
<td>$36.2</td>
<td>$37.0</td>
<td>$150.00</td>
<td>$111.0K</td>
<td>291</td>
<td align="right">30</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$7.15</td>
<td>$6.45</td>
<td>$7.15</td>
<td>$170.00</td>
<td>$67.2K</td>
<td>3.7K</td>
<td align="right">299</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$8.75</td>
<td>$7.8</td>
<td>$7.8</td>
<td>$175.00</td>
<td>$63.1K</td>
<td>936</td>
<td align="right">82</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$5.65</td>
<td>$5.3</td>
<td>$5.42</td>
<td>$195.00</td>
<td>$62.6K</td>
<td>280</td>
<td align="right">275</td>
</tr>
</tbody>
</table>

<h3>About Blackstone</h3>
Blackstone is the world's largest alternative-asset manager with $1.108 trillion in total asset under management, including $820.5 billion in fee-earning assets under management, at the end of September 2024. The company has four core business segments: private equity (25% of fee-earning AUM and 30% of base management fees), real estate (35% and 39%), credit and insurance (31% and 24%), and multi-asset investing (9% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).
In light of the recent options history for Blackstone, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Blackstone's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 1,360,113, the BX's price is up by 3.81%, now at $175.76. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 15 days.</li>
</ul>
<h3>What Analysts Are Saying About Blackstone</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $180.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Keefe, Bruyette &amp; Woods keeps a Market Perform rating on Blackstone with a target price of $174. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Blackstone with a target price of $192. 
&#x2A; Consistent in their evaluation, an analyst from Keefe, Bruyette &amp; Woods keeps a Market Perform rating on Blackstone with a target price of $175. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Equal-Weight rating on Blackstone with a target price of $180. 
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on Blackstone, maintaining a target price of $179. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Blackstone options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

What the Options Market Tells Us About Blackstone

Stifel analyst J. Bruce Chan maintains Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) with a Hold and raises the price target from $440 to $443.

SAIA

Stifel Maintains Hold on Saia, Raises Price Target to $443

Stifel analyst Drew Crum maintains OneWater Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) with a Buy and lowers the price target from $31 to $25.

ONEW

Stifel Maintains Buy on OneWater Marine, Lowers Price Target to $25

Stifel analyst Steven Wieczynski maintains OneSpaWorld Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSW#NASDAQ">OSW</a>) with a Buy and raises the price target from $24 to $25.

Stifel Maintains Buy on OneSpaWorld Holdings, Raises Price Target to $25

Wall Street is anticipating the inauguration of President-elect Donald Trump and contemplating what potential impacts the Department of Government Efficiency, led by Elon Musk and Vivek Ramaswamy, may<a href="https://www.benzinga.com/markets/equities/25/01/42938119/lockheed-martin-donates-1m-to-trumps-inaugural-committee-as-speculation-grows-over-elon-musk-led-doge-crackdown-on-traditional-defense-contracts"> have on defense contractors.&nbsp;</a>
Truist Securities analyst Michael Ciarmoli is optimistic on the defense sector and initiated coverage on Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) and Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) with Buy ratings and price targets of $579 and $544, respectively. 
Also Read: <a href="https://www.benzinga.com/news/legal/25/01/42979220/biden-announces-more-student-loan-forgiveness-bringing-debt-relief-to-nearly-5-million-borrowers">Biden Announces More Student Loan Forgiveness, Bringing Debt Relief To Nearly 5 Million Borrowers</a>
DOGE-related fears are "overblown," Ciarmoli said, adding that the recent pullbacks in both defense contractors' stocks have led to attractive entry points at current levels.
Ciarmoli highlighted DOGE's role as only an advisory board and noted that lawmakers and the appropriations committee still "call the shots" on budget and spending decisions. He also said Truist sees U.S. and NATO defense budgets increasing in 2026.&nbsp;
The Truist analyst sees Northrup Grumman's anchor nuclear triad B-21 Raider and Sentinel GBSD programs providing stability and growth. Ciarmoli also said U.S. and NATO defense spending will continue to grow and demand for missiles and munitions will be robust.
LMT, NOC Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Lockheed Martin shares are down 2.2% over the past month and Northrup Grumman shares are down 2.3% over the same period. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/43007213/experts-see-the-fed-on-hold-for-now-if-there-are-any-cuts-at-all-in-2025-after-decembers-sticky-consumer-inflation-report">Interest Rate Cuts &#8216;On Hold&#8230; If There Are Any At All In 2025&#8217; After December&#8217;s Sticky Consumer Inflation Report: Economists </a></li>
</ul>
Image: Shutterstock

Government

Initiation

Tech

DOGE Fears For Defense Contractors Lockheed Martin, Northrop Grumman 'Overblown,' Analyst Says

Edison International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) shares are trading higher Wednesday after Ladenburg Thalmann upgraded the stock from <a href="https://www.benzinga.com/analyst-stock-ratings">Sell to Neutral</a>.
What Happened: Ladenburg Thalmann analyst Paul Fremont upgraded Edison to a Neutral rating and set a price target of&nbsp;$56.50 on Wednesday. With the stock down approximately 20% over the past month, Fremont believes the company&#8217;s valuation is more in line with downside risks.
&#8220;With Edison trading at a 34% P/E discount we believe the stock reflects reasonable worst-case outcomes associated with the current California wildfires,&#8221; Fremont said in a new note to clients.
Uncertainty surrounding the wildfires in California have weighed on Edison shares in recent weeks. The company&#8217;s subsidiary Southern California Edison provides power to the areas surrounding Los Angeles.
Despite upgrading the stock, the Ladenburg Thalmann analyst lowered earnings estimates through 2027 to reflect the downside risk associated with reasonable worst-case outcomes. 
Negative outcomes for Edison include the potential for politicians to choose to use the California Wildfire Insurance Fund to cover claims, leaving utility companies vulnerable to another fire, as well as a potential determination that Southern California Edison equipment was involved in starting the fires. Fremont noted that a prudent determination could take up to 10 years. 
See Also: <a href="https://www.benzinga.com/25/01/42991108/california-wildfires-climate-change-impact-gavin-newsom-approval-asked-in-new-poll-young-voters-are-most-likely-to-believe">Gavin Newsom&#8217;s Crisis Management, Climate Change Impact On California Wildfires Covered In New Poll: What Americans Are Saying</a>
A lawsuit on behalf of property owners was reportedly filed against Southern California Edison alleging that witnesses saw flames below an Edison electrical line after a power interruption on Jan. 7.
Edison has filed an Electric Safety Incident Report&nbsp;indicating that it did not observe any interruption in power in its lines that would suggest its equipment was involved in starting the fires. Fremont doesn&#8217;t expect the final report to be available until the summer.
&#8220;Using a sum of the parts valuation approach we arrive at a price target of $56.50. Based on yesterday's closing price of $58.43 this represents a price depreciation potential of 3.3% and total return potential of 2.4% including a current dividend yield of 5.7%,&#8221; the Ladenburg Thalmann analyst said. 
EIX Price Action: <a href="http://benzinga.com/quote/eix">Edison International shares</a> were up 5.47% at $61.62 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Upgrades

Movers

Edison International Shares Are Moving Higher Wednesday: What's Driving The Action?

Stifel analyst J. Bruce Chan maintains Old Dominion Freight Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) with a Hold and lowers the price target from $178 to $176.

ODFL

Stifel Maintains Hold on Old Dominion Freight Line, Lowers Price Target to $176

Stifel analyst Ruben Roy maintains nLight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASR#NASDAQ">LASR</a>) with a Buy and lowers the price target from $17 to $14.

LASR

Stifel Maintains Buy on nLight, Lowers Price Target to $14

BOE's Taylor Says My Base Case On Rate Cuts Is Around 100 Basis Points This Year

Stifel analyst J. Bruce Chan maintains JB Hunt Transport Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) with a Hold and lowers the price target from $167 to $161.

JBHT

Stifel Maintains Hold on JB Hunt Transport Servs, Lowers Price Target to $161

Fed's Goolsbee Says Supply Chain Healing Was What Allowed Inflation To Come Down Without Damage To Labor Market

Stifel analyst Drew Crum maintains Brunswick (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BC#NYSE">BC</a>) with a Buy and lowers the price target from $95 to $86.

Stifel Maintains Buy on Brunswick, Lowers Price Target to $86

<a href="https://dbm.maryland.gov/budget/Documents/operbudget/2026/proposed/FY2026BudgetPresentation.pdf" title="https://dbm.maryland.gov/budget/Documents/operbudget/2026/proposed/FY2026BudgetPresentation.pdf">https://dbm.maryland.gov/budget/Documents/operbudget/2026/proposed/FY2026BudgetPresentation.pdf</a>

DKNG

FLUT

PENN

WYNN

Watching Gambling Stocks; Traders Circulate Maryland 2025 Budget Announcement From Governor Wes Moore, Says "Increase The Sports Wagering Tax Rate From 15% To 30%", "Increase The Table Game Tax Rate From 20% To 25%"

Comments

Bega Cheese

Bega Cheese (BGCHY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga